Recumbency after Selegiline (Anipryl) in dogs
The FDA has received 29 reports of recumbency in dogs after Selegiline. That is 0.7% of all reports for this medicine, compared with 0.4% across reports for all dog medicines, so it is reported unusually often with this medicine.
29Reports
0.0%Marked serious
0.0%Recovered
28%Died or euthanised
–Typical onset
Sponsored
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Selegiline treats canine cognitive dysfunction.
Products with this ingredient include Anipryl. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Selegiline cause recumbency in dogs?
- 29 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Recumbency with similar medicines
- Recumbency after Gabapentin 74 reports · 0.8% of its reports
All reported side effects of Selegiline in dogs · Medicines most reported with recumbency